IP Library Granted Patent US 10,456,562
Granted Patent B2
US 10,456,562 · App. 15/001,598 · Granted Oct 29, 2019

Bronchial sealant delivery methods and systems

Inventors: Sri Radhakrishnan (Cupertino, CA); Ryan Olivera (Granite Bay, CA)
Assignee: Pulmonx Corporation
A61M25/10A61B17/12104A61B17/12186A61M16/04A61M16/0404A61M16/0459A61M16/0479A61M16/0486A61M16/0434A61M2016/0027A61M2025/1052A61M2202/025A61M2202/0208A61M2205/3334A61M2205/3344A61M2205/505
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,456,562
App. No.
15/001,598
Granted
Oct 29, 2019
Kind
B2
Abstract

Devices, methods, and systems are provided for sealing a lung region. The target lung compartment is accessed and isolated via an isolation catheter. Fluid is delivered into the target lung compartment such that the target compartment is pressurized and the fluid flows through the collateral flow channel. A sealing agent is injected into the isolated lung compartment such that the agent is carried by the fluid to the collateral flow channel, thereby sealing the collateral flow channel. Variables of air flow may be measured or analyzed prior to injection of the sealing agent, or the sealing agent may be introduced into the region after a suitable time has elapsed.

Claims (22)

1. A method for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment, said method comprising:

accessing the target lung compartment through an isolation catheter;

isolating the target lung compartment;

delivering a fluid into the target lung compartment such that the target lung compartment is pressurized and the fluid flows through the collateral flow channel;

measuring pressure within the target lung compartment after the target lung compartment is pressurized;

determining that the target lung compartment comprises a collateral flow channel based on a measured drop in pressure; and

injecting an agent into the isolated target lung compartment such that the agent is carried by the fluid to the collateral flow channel, thereby sealing the collateral flow channel; wherein a start or a stop of the injection of the agent is timed by a processor based on the measured pressure.

2. The method of claim 1 , wherein the agent is a sealant.

3. The method of claim 1 , wherein the start of the injection of the agent is timed by the processor, wherein timing the start of the injection of the agent comprises starting the injection of the agent after the measured pressure drops below a predetermined threshold value.

4. The method of claim 3 , wherein timing the start of the injection of the agent comprises injecting the agent instantaneously upon measuring the drop in pressure.

5. The method of claim 1 , wherein the start of the injection of the agent is timed by the processor, wherein timing the start of the injection of the agent comprises waiting a predetermined period of time after measuring the drop in pressure before injecting the agent.

6. The method of claim 1 , wherein the stop of the injection of the agent is timed by the processor, wherein timing the stop of the injection of the agent comprises determining that the collateral flow channel has been sealed based on the measured pressure and stopping the injection of the agent after the collateral flow channel has been determined to be sealed.

7. A method for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment, said method comprising:

accessing the target lung compartment through an isolation catheter;

isolating the target lung compartment;

delivering a fluid into the target lung compartment such that the target lung compartment is pressurized and the fluid flows through the collateral flow channel;

measuring flow within the target lung compartment; and

injecting an agent into the isolated target lung compartment such that the agent is carried by the fluid to the collateral flow channel, thereby sealing the collateral flow channel; wherein a start or a stop of the injection of the agent is timed by a processor based on the measured flow.

8. The method of claim 7 , wherein the start of the injection of the agent is timed by the processor, wherein timing the start of the injection of the agent comprises starting the injection of the agent after the measured flow reaches a predetermined threshold value.

9. The method of claim 8 , wherein timing the start of the injection of the agent comprises injecting the agent instantaneously upon measuring a rise in flow.

10. The method of claim 7 , wherein the stop of the injection of the agent is timed by the processor, wherein timing the stop of the injection of the agent comprises determining that the collateral flow channel has been sealed based on the measured flow and stopping the injection of the agent after the collateral flow channel has been determined to be sealed.

11. The method of claim 7 , wherein the start of the injection of the agent is timed by the processor, wherein timing the start of the injection of the agent comprises waiting a predetermined period of time after measuring a rise in flow before injecting the agent.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2019
From: RADHAKRISHNAN, SRI; OLIVERA, RYAN
To: PULMONX CORPORATION
Reel/Frame 048963/0125 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
Continuity (2)
Provisional Application 62105649 · Jan 20, 2015
Related Publication 20160206301A1 · Jul 21, 2016
Cited By (3)
US 12,551,180 US 12,629,051 US 12,705,742